glp 1 blockers in food Companies Are Targeting Users of Weight-Loss Drugs With 'GLP-1 Friendly' Labels The Ultimate Guide to GLP-1:

Does eating before or after injection matter

Given existing evidence, triple combination therapy can be expected to provide additional cardiorenal protection, although further randomized controlled trials are needed to determine whether triple combination therapy actually has additive or synergetic effects compared with mono or dual therapy

Most patients experience some side effects, but the difference between a manageable adjustment period and a miserable one is rarely about the drug itself

Ethics declarations The authors declare no conflicts of interest

118 4 S

In patients with MASLD and established CVD, GLP-1-based therapies are strongly supported as a cornerstone treatment addressing both hepatic and cardiometabolic disease burden simultaneously